In support of their conclusion, increased bronchial hyperreactivity has previously been demonstrated in one synthesis. Class II mutations, including F508, are mutations that interfere with correct post-translational study 10 in heterozygote carriers. Further, an increase in atopic disease in this population has also been docuprocessing. The vast majority of mutant protein does not reach the apical membrane, although the protein mented. 11 Dahl et al postulate that the increase in bronchial hyperreactivity might explain the association itself is likely to retain normal function.
2 Class III mutations such as G551D (glycine to aspartic acid change between F508 carriers and asthma. In contrast, a high profile study by Schroeder et al suggested that obligate at position 551) give rise to chloride channels that show a reduced response to cAMP stimulation. Class IV heterozygote carriers (n=100) in CF families in the USA are protected from asthma in childhood and early mutations alter the ion selectivity or conductance of CFTR chloride channels. Class V mutations interfere adult life. 12 This was rapidly followed by a study by Mennie et al 13 who assessed samples from a British with correct transcription or translation, resulting in reduced levels of functional CFTR.
population screening programme (n=186) and did not find any association between CFTR mutations and A very strong genotype/phenotype correlation has been shown for pancreatic function in patients with CF; asthma, in keeping with previous work which also did not demonstrate such an association.
14 85% of patients suffer from pancreatic insufficiency (PI) while 15% are pancreatic sufficient (PS). Patients with Dahl et al evaluated the genetic status of their participants only for the absence or presence of the F508 PI generally carry "severe" CF mutations whereas PS is associated with "mild" mutations. As a general rule, mutation. However, other genetic variation such as the well documented thymidine tract polymorphism in mutations classified as nonsense, frameshift, splice-site, or amino acid deletions are "severe" mutations and intron 8 may also be involved. This polymorphism exists as a 9-, 7-or 5-thymidine variant. The 5-thymidine therefore confer the PI phenotype. However, there is no good correlation between the genotype and the variant (5T) significantly reduces the amount of normal CFTR transcript 15 because intron 8 is inefficiently severity of the pulmonary disease, which suggests that the lung phenotype might be modulated by additional spliced. The 5T variant on one allele, when coupled with a CFTR mutation on the second allele, has been genetic or environmental factors.
CF heterozygote carriers are generally disease free. associated with congenital bilateral absence of the vas deferens (CBAVD) in infertile males. This condition is The carrier frequency of CFTR mutations in the Caucasian population is 4-5%.
3 Founder effects and inthe most extensively studied example of "atypical" CF. Thus, in infertile males in whom renal abnormalities breeding have been shown to account for the high incidence of CF in some populations. 4 A heterozygote were excluded as a cause for CBAVD, CFTR mutations are found in 70% of affected males. 16 The combination advantage has also been postulated to explain this high incidence of CFTR mutations. Increased fertility 5 and of the 5T allele on one copy of the CFTR gene with a cystic fibrosis mutation on the other allele, or two increased resistance to tuberculosis, 6 general population. None of the patients had a mutation on both copies of the CFTR gene. However, four of the 18 patients with a CFTR mutation also had the 5T variant, which was presumed to be on the opposite allele. The patients with the CF mutations were significantly younger at presentation and included a higher pro-CFTR mutations has been determined in a number of portion of non-smokers. There was no significant other diseases that present with isolated features of the difference in the proportion of alcoholics and nonclassical CF phenotype (table 1) . The prevalence of alcoholics with mutations although non-alcoholics had CFTR mutations and the 5T variant in men with an approximately twofold greater incidence. In addition CBAVD is well documented and has already been disto the mutation analysis, a number of investigations cussed above. CFTR mutations have also been imfrequently used in the diagnosis of CF were assessed. plicated in men with azoospermia without CBAVD, These included sinopulmonary evaluation, meassuggesting an important role for CFTR in spermurements of basal potential differences in the nasal atogenesis and sperm maturation 23 24 but not in sperm epithelium, sweat chloride tests, and semen analysis.
malformations. 25 Miller et al found an increased freBased on these parameters a diagnosis of atypical CF quency of CFTR mutation in patients with allergic could not be confirmed in any of the patients presenting bronchopulmonary aspergillosis. However, this study with chronic pancreatitis.
was carried out on a small number of patients (n= Alcoholism, smoking, and a number of metabolic 11). 26 Two studies determined the incidence of CFTR disorders are major risk factors in the aetiology of mutations in patients with nasal polyposis but neither chronic pancreatitis; no cause can be identified in the found an increased frequency of CFTR mutations in remaining 40% or so of affected patients. 20 Inthese populations. 27 28 Finally, patients with bronterpretation of the data in the present study is comchiectasis or COPD have also been screened for CFTR plicated by the heterogeneous aetiology of the patients mutations. Several studies report evidence for an inchosen. Pancreatitis was related to alcoholism in 53% volvement of CFTR in at least some cases of whilst 74% of patients were smokers, making it more bronchiectasis 29 30 but not in COPD, 31 32 in agreement difficult to determine the relative contribution of CFTR with the findings of Dahl et al discussed above. mutations. Clearly, the influence of smoking will also be important with regard to the use of lung function tests in the diagnosis of CF lung disease. Thus, obstructive lung function was found in 22% and 25%, respectively, of patients with and without CFTR mutations. Similarly, measurements of sweat electrolyte concentrations, the gold standard for diagnosis of CF, are hampered by the knowledge that alcoholism increases sweat electrolyte levels.
Despite these potential confounding factors, the results presented here are in agreement with a recent study which also determined the prevalence of CFTR mutations and the 5T polymorphism in patients with chronic idiopathic pancreatitis. 21 Nine of 27 patients had a CFTR mutation or the 5T variant, or both. In three patients both CFTR alleles were affected; the genotypes were the two most common in patients with CBAVD. As is the case with CBAVD subjects, none of these patients fulfilled traditional diagnostic criteria for the classic CF phenotype. Unlike the study by Sharer et al, this study did not find evidence for an increased frequency of the 5T variant in patients with chronic idiopathic pancreatitis. However, in a recent correspondence Sharer et al recognised a mistake in calculating the carrier frequency of the 5T variant and confirmed that the 5T variant is not associated with chronic pancreatitis. 22 In our view, given the concordant findings of both these studies with respect to the increased frequency of CFTR mutations, there is compelling evidence for a role for CFTR mutations in the aetiology of chronic pancreatitis. Apart from asthma and pancreatitis, the frequency of LEARNING POINTS * The pathogenic consequences of mutated CFTR can be found in diseases other than classical cystic fibrosis. * Chronic pancreatitis appears to be one such disease; the link with asthma is less certain. * The presence of the 5T variant in intron 8 should be considered in addition to "classical" CF mutations. 
